Jaiman Manasi — SEC insider filings

SEC reporting owner CIK 2045686. 3 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-06-13 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aardvark Therapeutics, Inc. (AARD)Chief Medical Officer3——8

Insider filings — Jaiman Manasi

FiledFormIssuerReported transactionsSource
2026-11-104Aardvark Therapeutics, Inc. (AARD)Grant/award (A): 70,549 (derivative) · Disposition to issuer (D): 70,549 (derivative) · Grant/award (A): 126,999 (derivative) · Disposition to issuer (D): 126,999 (derivative) · Grant/award (A): 177,012 (derivative) · Disposition to issuer (D): 177,012 (derivative)EDGAR
2026-02-114Aardvark Therapeutics, Inc. (AARD)Grant/award (A): 70,549 (derivative) @ $0EDGAR
2025-06-134Aardvark Therapeutics, Inc. (AARD)Grant/award (A): 126,999 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2045686 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs